Evaluation of Plasma Biomarkers for Causal Association With Peripheral Artery Disease
Arteriosclerosis, Thrombosis, and Vascular Biology · 2024
DOI: 10.1161/atvbaha.124.320674 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2024. Verfasst von Pranav Sharma und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Perelman School of Medicine (P.S., S.M.D.), University of Pennsylvania, Philadelphia. Hauptthemen laut MEDLINE: Peripheral Arterial Disease, Biomarkers, Genome-Wide Association Study, Mendelian Randomization Analysis. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: CSRD VA, NHLBI NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Hundreds of biomarkers for peripheral artery disease (PAD) have been reported in the literature; however, the observational nature of these studies limits causal inference due to the potential of reverse causality and residual confounding. We sought to evaluate the potential causal impact of putative PAD biomarkers identified in human observational studies through genetic causal inference methods. METHODS: Putative circulating PAD biomarkers were identified from human observational studies through a comprehensive literature search based on terms related to PAD using PubMed, Cochrane, and Embase. Genetic instruments were generated from publicly available genome-wide association studies of circulating biomarkers. Two-sample Mendelian randomization was used to test the association of genetically determined biomarker levels with PAD using summary statistics from a genome-wide association study of 31 307 individuals with and 211 753 individuals without PAD in the Veterans Affairs Million Veteran Program and replicated in data from FinnGen comprised of 11 924 individuals with and 288 638 individuals without PAD. RESULTS: We identified 204 unique circulating biomarkers for PAD from the observational literature, of which 173 were genetically instrumented using genome-wide association study results. After accounting for multiple testing (false discovery rate,
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Perelman School of Medicine (P.S., S.M.D.), University of Pennsylvania, Philadelphia.
- Veterans Affairs Palo Alto Healthcare System, CA (D.K., P.S.T.).
- Division of Vascular Surgery (D.K.), Stanford University School of Medicine, CA.
- Department of Genetics (B.F.V., S.M.D.), University of Pennsylvania, Philadelphia.
- Department of Systems Pharmacology and Translational Therapeutics (B.F.V.), University of Pennsylvania, Philadelphia.
- Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA (B.F.V., M.G.L., S.M.D.).
ORCID-Profile: Pranav Sharma, Derek Klarin, Benjamin F Voight, Philip S Tsao, Michael G Levin
Förderung
- CSRD VA
- NHLBI NIH HHS
- NIDDK NIH HHS
Zitieren
APA
Sharma, P., Klarin, D., Voight, B. F., Tsao, P. S., Levin, M. G., & Damrauer, S. M. (2024). Evaluation of Plasma Biomarkers for Causal Association With Peripheral Artery Disease. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.124.320674
Vancouver
Sharma P, Klarin D, Voight BF, Tsao PS, Levin MG, Damrauer SM. Evaluation of Plasma Biomarkers for Causal Association With Peripheral Artery Disease. Arteriosclerosis, Thrombosis, and Vascular Biology. 2024. doi:10.1161/atvbaha.124.320674
BibTeX
@article{Sharma2024,
author = {Sharma, Pranav and Klarin, Derek and Voight, Benjamin F and Tsao, Philip S and Levin, Michael G and Damrauer, Scott M},
title = {Evaluation of Plasma Biomarkers for Causal Association With Peripheral Artery Disease},
journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
year = {2024},
doi = {10.1161/atvbaha.124.320674}
}
EUVIMED